心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

三七总皂苷制剂临床应用中国专家共识

2021-09-27 国家中医心血管病临床医学研究中心 三七总皂苷制剂临床应用中国专家共识 国家中医心血管病临床医学研究中心

三七总皂苷制剂

目前已从三七中分离、提取、鉴定出了百余种化合物,基本阐明了三七中主要化合物的结构组成,其中三七总皂苷(Panax notoginseng saponins,PNS)是三七的主要有效成分。 

中文标题：

三七总皂苷制剂临床应用中国专家共识

发布机构：

国家中医心血管病临床医学研究中心

发布日期：

2021-09-27

简要介绍：

三七具有散瘀止血、消肿定痛的功效,相关文字记载首见于明代异远真人的《救伤秘旨跌损妙方》,其中记载"参三七"组方40条,广泛用于治疗外伤出血等疾病。明代李时珍在《本草纲目》中指出三七具有"止血、散血、定痛"的功效,清代赵学敏在《本草纲目拾遗》中补充记载了三七的补益作用,认为"人参补气第一,三七补血第一"。目前已从三七中分离、提取、鉴定出了百余种化合物,基本阐明了三七中主要化合物的结构组成,其中三七总皂苷(Panax notoginseng saponins,PNS)是三七的主要有效成分。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=三七总皂苷制剂临床应用中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8c4bd1c0022e03eb, title=三七总皂苷制剂临床应用中国专家共识, enTitle=, guiderFrom=三七总皂苷制剂临床应用中国专家共识 国家中医心血管病临床医学研究中心, authorId=0, author=, summary=目前已从三七中分离、提取、鉴定出了百余种化合物,基本阐明了三七中主要化合物的结构组成,其中三七总皂苷(Panax notoginseng saponins,PNS)是三七的主要有效成分。 , cover=https://img.medsci.cn/20211123/1637680990922_5579292.png, journalId=0, articlesId=null, associationId=2147, associationName=国家中医心血管病临床医学研究中心, associationIntro=国家中医心血管病临床医学研究中心, copyright=0, guiderPublishedTime=Mon Sep 27 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">三七具有散瘀止血、消肿定痛的功效,相关文字记载首见于明代异远真人的《救伤秘旨跌损妙方》,其中记载"参三七"组方40条,广泛用于治疗外伤出血等疾病。明代李时珍在《本草纲目》中指出三七具有"止血、散血、定痛"的功效,清代赵学敏在《本草纲目拾遗》中补充记载了三七的补益作用,认为"人参补气第一,三七补血第一"。目前已从三七中分离、提取、鉴定出了百余种化合物,基本阐明了三七中主要化合物的结构组成,其中三七总皂苷(Panax notoginseng saponins,PNS)是三七的主要有效成分。&nbsp;</span></p>, tagList=[TagDto(tagId=118388, tagName=三七总皂苷制剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2027, appHits=96, showAppHits=0, pcHits=564, showPcHits=1931, likes=2, shares=4, comments=5, approvalStatus=1, publishedTime=Tue Nov 23 23:27:04 CST 2021, publishedTimeString=2021-09-27, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 23 23:24:43 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 00:18:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=三七总皂苷制剂临床应用中国专家共识.pdf)])
三七总皂苷制剂临床应用中国专家共识.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191761, encodeId=590f1191e613d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Thu Feb 10 11:51:42 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075787, encodeId=141910e5787ef, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8016151576, createdName=ms7000001932980833, createdTime=Wed Dec 01 10:19:09 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074215, encodeId=b44c10e42152b, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073379, encodeId=dfa910e337977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:03:40 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2022-02-10 ms1000001784410327

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191761, encodeId=590f1191e613d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Thu Feb 10 11:51:42 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075787, encodeId=141910e5787ef, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8016151576, createdName=ms7000001932980833, createdTime=Wed Dec 01 10:19:09 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074215, encodeId=b44c10e42152b, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073379, encodeId=dfa910e337977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:03:40 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-12-01 ms7000001932980833

    #学习#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191761, encodeId=590f1191e613d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Thu Feb 10 11:51:42 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075787, encodeId=141910e5787ef, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8016151576, createdName=ms7000001932980833, createdTime=Wed Dec 01 10:19:09 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074215, encodeId=b44c10e42152b, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073379, encodeId=dfa910e337977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:03:40 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-11-26 H8888888

    不错 学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191761, encodeId=590f1191e613d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74e06497418, createdName=ms1000001784410327, createdTime=Thu Feb 10 11:51:42 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075787, encodeId=141910e5787ef, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8016151576, createdName=ms7000001932980833, createdTime=Wed Dec 01 10:19:09 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074215, encodeId=b44c10e42152b, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:21 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073379, encodeId=dfa910e337977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:03:40 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-11-24 微探

    学习学习

    0